- News & Views
- Published:
Alzheimer’s disease
Nature Aging (2025)Cite this article
191 Accesses
1 Altmetric
Subjects
Current diagnostic approaches lack sensitivity for the early-stage tau changes that precede neurofibrillary tangles in Alzheimer’s disease. Islam, Hill, Abrahamson and colleagues identify phospho-tau Ser262 and Ser356 as potential biomarkers for early-stage tau aggregation in Alzheimer’s disease. These findings could revolutionize the early diagnosis of and therapeutic strategies for Alzheimer’s disease, which offers hope for more effective interventions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Self, W. K. & Holtzman, D. M. Nat. Med. 29, 2187–2199 (2023).
Chang, C. W., Shao, E. & Mucke, L. Science 371, eabb8255 (2021).
Otero-Garcia, M. et al. Neuron 110, 2929–2948 (2022).
Livingston, G. et al. Lancet 390, 2673–2734 (2017).
Jack, C. R. Jr. et al. Alzheimers Dement. 20, 5143–5169 (2024).
Jiang, Y. et al. Alzheimers Dement. 20, 2000–2015 (2024).
Islam, T. et al. Nat. Med. 31, 574–588 (2025).
Ossenkoppele, R., van der Kant, R. & Hansson, O. Lancet Neurol. 21, 726–734 (2022).
Ariza, M., Kolb, H. C., Moechars, D., Rombouts, F. & Andrés, J. I. J. Med. Chem. 58, 4365–4382 (2015).
Macedo, A. C. et al. J. Nucl. Med. 64, 1171–1178 (2023).
Leuzy, A. et al. Mol. Psychiatry 24, 1112–1134 (2019).
Chatterjee, M. et al. Nat. Med. 30, 1771–1783 (2024).
Tracy, T. E. et al. Cell 185, 712–728 (2022).
Chu, Y. et al. Brain 147, 444–457 (2024).
Xiang, J. et al. Neuron 112, 3585–3601 (2024).
Acknowledgements
We thank Y. Yang for her assistance with drawing the figure. The authors were supported by the National Natural Science Foundation of China (grants 82471445 and 32170988 to R.L.), and a grant from the Startup Foundation for Introducing Talent of Lanzhou University (grant 561120215 to R.L.).
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Luo, R., Yu, JT. New biomarkers for early-stage tau pathology in Alzheimer’s disease. Nat Aging (2025). https://doi.org/10.1038/s43587-025-00854-w
Published:
DOI: https://doi.org/10.1038/s43587-025-00854-w